Precision Medicine in COPD: Review of Mepolizumab for Eosinophilic COPD

Breathe - United Kingdom
doi 10.1183/20734735.026318
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

A Pilot Randomised Clinical Trial of Mepolizumab in COPD With Eosinophilic Bronchitis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

Triple Therapy Trials in COPD: A Precision Medicine Opportunity

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2018English

Mepolizumab Als Zusatztherapeutikum Bei Eosinophiler COPD

Pneumologie
MedicinePulmonaryRespiratory Medicine
2018English

Burden of Disease Associated With a COPD Eosinophilic Phenotype

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2018English

Network Medicine Analysis of COPD Multimorbidities

Respiratory Research
PulmonaryRespiratory Medicine
2014English

Eosinophilic Inflammation in COPD: Prevalence and Clinical Characteristics: Table 1–

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2014English

Symptom Variability in COPD: A Narrative Review

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2013English

Cognitive Impairment in COPD: A Systematic Review

Jornal Brasileiro de Pneumologia
PulmonaryRespiratory Medicine
2015English

Medicines for COPD

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy